Does SITAGLIPTIN Cause Metastases to lung? 141 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Metastases to lung have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.7% of all adverse event reports for SITAGLIPTIN.
141
Reports of Metastases to lung with SITAGLIPTIN
0.7%
of all SITAGLIPTIN reports
117
Deaths
117
Hospitalizations
How Dangerous Is Metastases to lung From SITAGLIPTIN?
Of the 141 reports, 117 (83.0%) resulted in death, 117 (83.0%) required hospitalization, and 35 (24.8%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
RIBOCICLIB (649)
CAPECITABINE (616)
BEVACIZUMAB (578)
PACLITAXEL (563)
FULVESTRANT (560)
EVEROLIMUS (522)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
Which SITAGLIPTIN Alternatives Have Lower Metastases to lung Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE